NCT04405674 2021-11-22
Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC
Shanghai Chest Hospital
Phase 2 Unknown
Shanghai Chest Hospital
Emory University
Southwest Hospital, China
Zhejiang University
The First Affiliated Hospital of Guangzhou Medical University